Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Mapping the Molecular Interaction Profile of 5-(1,3,4-Oxadiazol-2-yl)-Substituted Pyrimidine Hybrids in Diabetes Mellitus: Synthetic Development, Enzyme Kinetics, Molecular Recognition, In Vivo Toxicology and Therapeutic Translation.

Created on 15 Nov 2026

Authors

M M Khowdiary

Published in

Chemico-biological interactions. Pages 112428. Nov 14, 2026. Epub Nov 14, 2026.

Abstract

Diabetes mellitus is a major metabolic disorder characterized by persistent hyperglycemia and remains a significant therapeutic challenge. Inhibition of α-amylase and α-glucosidase, key enzymes involved in carbohydrate digestion, represents an effective strategy for controlling postprandial glucose levels. In the present study, a novel series of pyrimidine-oxadiazole hybrid derivatives was designed, synthesized, structurally characterized, and evaluated using complementary experimental and computational approaches. The synthesized compounds exhibited promising inhibitory activity against both enzymes, with compound 5 having IC50 = 5.20 ± 0.10 μM and 5.90 ± 0.30 μM for α-amylase and α-glucosidase, respectively,emerging as the most potent derivative against α-amylase and α-glucosidase, showing greater activity than the reference drug acarbose. Structure-activity relationship analysis revealed that the electronic and steric characteristics of substituents substantially influenced enzyme inhibitory activity. Molecular docking demonstrated favorable binding orientations. Density functional theory (DFT) calculations provided insights into the electronic properties, frontier molecular orbitals, and chemical reactivity of the active derivatives. Furthermore, in silico ADMET profiling indicated favorable drug-like and pharmacokinetic characteristics. Overall, these findings identify compound 5 and the pyrimidine-oxadiazole scaffold as promising frameworks for further development of dual α-amylase/α-glucosidase inhibitors.

PMID:
43033980
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement